Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
VRTX US​

Vertex Pharmaceuticals Inc / Ma(VRTX US)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

Financials(127)

Expand
  • 10-QQ2ended 30 Jun 20264 Aug
  • 10-QQ1ended 31 Mar 20265 May
  • 10-KFY 2025ended 31 Dec 202513 Feb
  • 10-QQ3ended 30 Sept 20254 Nov 2025
  • 10-QQ2ended 30 Jun 20255 Aug 2025
  • 10-QQ1ended 31 Mar 20256 May 2025
  • 10-KFY 2024ended 31 Dec 202413 Feb 2025
  • 10-QQ3ended 30 Sept 20245 Nov 2024
  • 10-QQ2ended 30 Jun 20242 Aug 2024
  • 10-QQ1ended 31 Mar 20247 May 2024
  • 10-QQ3ended 30 Sept 20237 Nov 2023
  • 10-QQ2ended 30 Jun 20232 Aug 2023
  • 10-QQ1ended 31 Mar 20232 May 2023
  • 10-KFY 2022ended 31 Dec 202210 Feb 2023
  • 10-QQ3ended 30 Sept 202228 Oct 2022

Events(294)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers20 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers1 Sep
  • 8-KResults of Operations and Financial Condition3 Aug
  • 8-KEntry into a Material Definitive Agreement6 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers13 May
  • 8-KResults of Operations and Financial Condition4 May
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers29 Apr
  • 8-KOther Events31 Mar
  • 8-KResults of Operations and Financial Condition12 Feb
  • 8-KResults of Operations and Financial Condition3 Nov 2025
  • 8-KResults of Operations and Financial Condition4 Aug 2025
  • 8-KOther Events19 May 2025
  • 8-KSubmission of Matters to Shareholder Vote14 May 2025
  • 8-KResults of Operations and Financial Condition5 May 2025
  • 8-KOther Events28 Mar 2025

Insider Ownership(2.6K)

Expand
  • 4Statement of changes in beneficial ownership22 Oct
  • 3Initial statement of beneficial ownership22 Oct
  • 4Statement of changes in beneficial ownership19 Oct
  • 4Statement of changes in beneficial ownership19 Oct
  • 4Statement of changes in beneficial ownership10 Sep
  • 3Initial statement of beneficial ownership10 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Statement of changes in beneficial ownership31 Aug
  • 4Statement of changes in beneficial ownership23 Jul
  • 4Statement of changes in beneficial ownership23 Jul
  • 4Statement of changes in beneficial ownership17 Jul
  • 4Statement of changes in beneficial ownership17 Jul
  • 4Statement of changes in beneficial ownership7 Jul
  • 4Statement of changes in beneficial ownership7 Jul
  • 4Statement of changes in beneficial ownership6 Jul

Beneficial Ownership(178)

Expand
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA14 May
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA14 May
  • SC 13GVERTEX PHARMACEUTICALS INC / MA30 Apr
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA27 Mar
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA12 Feb
  • SC 13GVERTEX PHARMACEUTICALS INC / MA13 May 2025
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA13 Feb 2025
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA12 Feb 2025
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA10 Apr 2024
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA13 Feb 2024
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA9 Feb 2024
  • SC 13G/AVERTEX PHARMACEUTICALS INC / MA9 Feb 2024
  • SC 13GVERTEX PHARMACEUTICALS INC / MA25 Jan 2024
  • SC 13D/AKymera Therapeutics, Inc.5 Jun 2023
  • SC 13GVERTEX PHARMACEUTICALS INC / MA13 Feb 2023

Other Ownership(188)

Expand
  • 144SACHS BRUCE I27 Aug
  • 144Tatsis Ourania2 Jul
  • 144McKechnie Duncan2 Jul
  • 144Liu Joy1 Jul
  • 144Bozic Carmen26 Jun
  • 144Bozic Carmen18 Jun
  • 144Bozic Carmen15 Jun
  • 144Bozic Carmen5 Jun
  • 144Liu Joy1 Jun
  • 144Bozic Carmen29 May
  • 144Bozic Carmen15 May
  • 144Bunnage Mark E.15 May
  • 144Bozic Carmen12 May
  • 144Biller Jonathan6 May
  • 144Bhatia Sangeeta N.4 May

Proxies(73)

Expand
  • DEFA14ADefinitive additional materials29 Apr
  • ARSAnnual report to security holders2 Apr
  • DEFA14ADefinitive additional materials2 Apr
  • DEF 14ADefinitive proxy statement2 Apr
  • ARSAnnual report to security holders3 Apr 2025
  • DEFA14ADefinitive additional materials3 Apr 2025
  • DEF 14ADefinitive proxy statement3 Apr 2025
  • PX14A6GNotice of exempt solicitation16 Apr 2024
  • ARSAnnual report to security holders4 Apr 2024
  • DEFA14ADefinitive additional materials4 Apr 2024
  • DEF 14ADefinitive proxy statement4 Apr 2024
  • ARSAnnual report to security holders6 Apr 2023
  • DEFA14ADefinitive additional materials6 Apr 2023
  • DEF 14ADefinitive proxy statement6 Apr 2023
  • DEF 14ADefinitive proxy statement7 Apr 2022

Registrations(121)

Expand
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8 POSPost-effective amendment (employee benefit plan)13 May
  • S-8Registration statement (employee benefit plan)13 May
  • S-3ASRAutomatic shelf registration statement (S-3)13 Feb 2025
  • S-8Registration statement (employee benefit plan)5 Aug 2022
  • S-3ASRAutomatic shelf registration statement (S-3)9 Feb 2022
  • S-8Registration statement (employee benefit plan)1 Aug 2019
  • S-8Registration statement (employee benefit plan)1 Aug 2019
  • S-3ASRAutomatic shelf registration statement (S-3)13 Feb 2019
  • S-8Registration statement (employee benefit plan)26 Jul 2018

Filing Review Correspondence(17)

Expand
  • CORRESPFiling review correspondence1 Apr
  • UPLOADFiling review upload7 May 2025
  • CORRESPFiling review correspondence5 May 2025
  • UPLOADFiling review upload7 Apr 2025
  • CORRESPFiling review correspondence26 Sep 2022
  • CORRESPFiling review correspondence7 Feb 2017
  • CORRESPFiling review correspondence16 Dec 2016
  • CORRESPFiling review correspondence19 Oct 2016
  • CORRESPFiling review correspondence17 Oct 2016
  • CORRESPFiling review correspondence12 Aug 2016
  • CORRESPFiling review correspondence11 Jul 2016
  • CORRESPFiling review correspondence27 May 2016
  • CORRESPFiling review correspondence11 May 2015
  • UPLOADFiling review upload8 Jun 2006
  • CORRESPFiling review correspondence2 May 2006

SEC Orders And Notices(21)

Expand
  • CT ORDERConfidential treatment order19 Mar 2019
  • CT ORDERConfidential treatment order3 Apr 2018
  • CT ORDERConfidential treatment order13 Jun 2017
  • CT ORDERConfidential treatment order7 Apr 2017
  • CT ORDERConfidential treatment order9 Feb 2017
  • CT ORDERConfidential treatment order30 Mar 2016
  • CT ORDERConfidential treatment order17 Dec 2015
  • CT ORDERConfidential treatment order11 Apr 2014
  • CT ORDERConfidential treatment order11 Apr 2014
  • CT ORDERConfidential treatment order25 Mar 2014
  • CT ORDERConfidential treatment order10 Sep 2012
  • CT ORDERConfidential treatment order10 Sep 2012
  • CT ORDERConfidential treatment order6 Mar 2012
  • CT ORDERConfidential treatment order8 Feb 2012
  • CT ORDERConfidential treatment order8 Feb 2012

Tender Offers And Going Private(7)

Expand
  • SC TO-T/ATender offer statement (third-party, amendment)20 May 2024
  • SC TO-T/ATender offer statement (third-party, amendment)10 May 2024
  • SC TO-T/ATender offer statement (third-party, amendment)8 May 2024
  • SC TO-TTender offer statement (third-party)22 Apr 2024
  • SC TO-CTender offer statement (communication)11 Apr 2024
  • SC TO-CTender offer statement (communication)11 Apr 2024
  • SC TO-CTender offer statement (communication)10 Apr 2024

Exempt Offerings(1)

Expand
  • DNotice of exempt offering of securities (Reg D)18 Mar 2009

Other(8)

Expand
  • SEC STAFF LETTERSEC STAFF LETTER26 Feb 2020
  • SEC STAFF LETTERSEC STAFF LETTER7 Feb 2020
  • NO ACTAUTO-GENERATED PAPER DOCUMENT10 Feb 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT7 Mar 2016
  • NO ACTAUTO-GENERATED PAPER DOCUMENT25 Feb 2015
  • 10-K40510-K40526 Mar 1998
  • 10-K40510-K40528 Mar 1997
  • 10-C10-C16 Aug 1996